key: cord-1007992-z9vjo98p
authors: de Candia, Paola; Prattichizzo, Francesco; Garavelli, Silvia; Matarese, Giuseppe
title: T Cells: Warriors of SARS-CoV-2 Infection
date: 2020-11-13
journal: Trends Immunol
DOI: 10.1016/j.it.2020.11.002
sha: 642e9a47db26d9d3919fe49b8df4a7db3e864b2f
doc_id: 1007992
cord_uid: z9vjo98p

Severe infection with SARS-CoV-2 is characterized by massive cytokine release and T cell loss. The exaggerated host immune response, incapable of viral clearance, instead aggravates respiratory distress, as well as cardiac and/or damage to other organs. The mortality pattern of SARS-CoV-2 infection, higher in older vs younger adults and almost absent in children, is possibly caused by the effects of age and pre-existing co-morbidities on innate and adaptive immunity. Here, w speculate that the abnormal and excessive immune response to SARS-CoV-2 infection partly depends on T cell immunological memory, that is more pronounced in adults compared to children, and may significantly contribute to immunopathology and massive collateral damage in COVID-19 patients.

In conclusion, we posit that a simple lymphocyte enumeration in circulation might become useful in identifying patients at highest risk of developing an overly harmful response to SARS-CoV-2 infection.

A growing number of clinical observations show how decreases in blood lymphocyte count and lymphocyte percentage are frequently associated with an increase in the number of neutrophils, not only in the blood but also in the bronchoalveolar lavage fluid (BALF) of COVID-19 patients [18, [41] [42] [43] (Figure 1) . Two meta-analyses draw superimposable conclusions that subjects with a more severe COVID-19 progression, compared to non-severe, harbor more neutrophils, less lymphocytes, higher neutrophil-to-lymphocyte ratios (NLR) and low lymphocyte-to-C-reactive protein ratios (LCR), proposing the potential use of these parameters in routine laboratory blood tests as putative reliable biomarkers of poor prognosis in COVID-19 patients [44, 45] .

While minimal concentrations of pro-inflammatory cytokines and chemokines were found in patients recovering from COVID-19, even in the symptomatic phase [8] , COVID-19 patients with ARDS suffered from a cytokine storm, characterized by higher plasma concentrations of Interleukin (IL)-1, IL-2, IL-6, IL-7, IL-8, IL-10, granulocyte-colony stimulating factor (GCSF), monocyte chemoattractant protein (MCP)-1 and tumor necrosis factor (TNF)-α, relative to patients without ARDS; this has directly implicated the excessive release of cytokines in COVID-19 pathology [6, 6 directly promoting lymphocyte necrosis [52] . Recently, through the examination of human post mortem thoracic lymph nodes and spleens, aberrant extra-follicular TNF-α amounts were proposed to contribute to a specific block in BCL-6 + T follicular helper cell differentiation (Box 1), as well as in the dramatic loss of germinal centers in acute SARS-CoV-2 infection [53] . The vicious cycle of cytokine storm and T lymphocyte loss makes cytokines promising putative therapeutic targets for COVID-19. Accordingly, the intravenous administration of tocilizumab -a specific blocker of the IL-6 pathway-to severe COVID-19 patients, has been accompanied by an increase in the absolute lymphocyte blood count within the first day [50] ; this has suggested that in immune-dysregulated patients, increased circulating cytokines might sharpen defective lymphocyte functions, thus contributing to an ineffective antiviral response. Along the same lines, subcutaneous administration of anakinra -a recombinant IL-1 receptor antagonist-to hospitalized patients with severe COVID-19-related bilateral pneumonia, significantly decreased the need for mechanical ventilation and contributed to reduced mortality compared with controls [54] .

Since T cells are known to dampen overactive innate immune responses during viral infections [55, 56] , it is reasonable to speculate that T cell loss might exacerbate certain pathological inflammatory responses during SARS-CoV-2 infection and sustaining a dysregulated T cell-cytokine loop, although this warrants rigorous investigation. On the one hand, pathogenic T cells themselves can contribute to systemic concentrations of pro-inflammatory cytokines [57] . On the other hand, an overt inflammatory response might also play an immunosuppressive role. Recent work revealed the occurrence of neutrophil precursors and dysfunctional mature neutrophils with immunosuppressive properties (e.g. expressing the immune checkpoint molecule PD-L1) in the blood of severe COVID-19 patients, presumably further decreasing T cell numbers in circulation [58] . Collectively, these studies suggests a picture of a feed-forward loop that might comprise the pro-inflammatory actions of innate immune cells, the effect of cytokines in the immune milieu, and T cell loss.

Several studies show that, while numerically decreased, both CD4 + and CD8 + T cells from severe COVID-19 patients present a dysregulated status of activation and function, characterized by high concentrations of inflammatory genes, such as those encoding IL-2R, IL-6, JUN, FOS, perforin, granzymes, as well as the co-expression of HLA-DR, CD38, and CD45RO activation markers [21, 46, 59, 60] (Figure 1 ). This activation status seems to be unspecific. Indeed, the majority of CD8 + T cells belongs to expanded clones in patients with moderate SARS-CoV-2 infection, in which a higher amplification index has been reported, and CD8 + T cells preferentially expresses tissueresidence genes, such as those encoding CXCR-6, and XCL1; by contrast, CD8 + T cells from patients with severe/critical infection are less expanded, more proliferative, and more phenotypically heterogeneous [43] . Regarding function, in parallel with excessive blood CD8 + T cell activation, CD4 + T cells from severe COVID-19 cases have demonstrated a higher release in cytotoxic granules, and a marked decrease in the secretion of functional molecules such as IFN- and TNF-α compared to CD4 + T cells from a group of mild COVID19 patients [59, 61] . Moreover, a transcriptomics study showed substantially reduced adaptive immunity gene expression (MHC class II and T cell activation genes e.g. coding for IL-23A and CD74) in peripheral blood bulk T cells from severe COVID-19 patients [62] . In another study, blood CD8 + T cells isolated from severely ill subjects were not only drastically reduced, but also showed a decreased percentage of positivity for CD107a, IFN-, IL-2 and lower expression of granzyme B relative to mild COVID-19 patients [63] . Unlike subjects showing mild symptoms, no correlation was found between SARS-CoV-2-reactive IFN- producing blood CD8 + T cell counts and SARS-CoV-2-specific antibody titers in severe COVID19 patients, suggesting a lack of coordination between cellular and humoral immunity in these subjects [64] . Moreover, a skewing of CD8 + T cells towards a terminally J o u r n a l P r e -p r o o f differentiated/senescent phenotype, also displaying reduced anti-viral cytokine production capability, was reported in COVID-19 patients who required intensive care [65] .

The apparently conflicting observations of both hyper-activation and functional impairment of T cell compartments remain enigmatic, but might potentially be reconciled when considering that persistent stimulation and long-term activation are known to induce both CD4 + and CD8 + T cell exhaustion [66] [67] [68] . Accordingly, protein expression of three exhaustion markers, i.e. the CD28 family member programmed cell death marker 1 (PD-1), the receptor mucin domain-containing protein-3 (TIM-3) and the ITIM-bearing receptor NKG2A [69] [70] [71] were increased in both peripheral CD4 + and CD8 + T cells from severe COVID-19 patients, a finding that was paralleled by the decreased expression of co-stimulatory molecule CD28 in both subsets [21, 46, 63, 72] ( Figure 1) .

From another angle, effector T cell hyperactivation (and subsequent exhaustion) might be functionally linked to the reported significant reduction of circulating regulatory T cells (Treg) in patients with severe compared to moderate COVID-19 [19, 21, 26] (Box 1) (Figure 1 ). In particular, the proportion of both blood naïve (CD45RA + ) and induced (CD45RO + ) Treg cells declined in severely ill patients, suggesting an important impairment in the immunoregulatory arm of the T cell-mediated response [26] . An increased proportion of blood T follicular helper cells responding to SARS-CoV-2 correlated with reduced numbers of circulating SARS-CoV-2-reactive Treg cells by large-scale single-cell transcriptomic analysis in COVID-19 patients [73] . Since Treg cells are known to play an important role in limiting the host antiviral response and the consequent tissue immunopathology [74, 75] , their reduction might have a relevant impact on fueling systemic inflammation in severe COVID-19 patients, a hypothesis that deserves to be fully explored.

The quality (T cell subset differentiation), beyond magnitude and regulation, of the immune response might also be crucial [76, 77] . The strongest T cell responses to SARS-CoV-2 are directed against the spike (S) surface glycoprotein, and SARS-CoV-2-specific T cells predominantly produce effector and Th1 (Box 1) cytokines [6, 11, 78 ]-a response that is effective in keeping the J o u r n a l P r e -p r o o f infection under control via macrophages and cytotoxic T cells. However, in severe COVID-19 patients, the signals of a Th2 immune response in peripheral blood have been reported, as evidenced by a high proportion of basophils and degranulated eosinophils and increased concentration of Th2 cytokines (such as IL-4 and IL-10) relative to controls (Box 1) [6, 78, 79] . In addition, higher numbers of proinflammatory CCR6 + Th17 cells in peripheral blood have also been reported in severe relative to mild cases of COVID-19, and thus, Th17 cell-related pro-inflammatory cytokine IL-17 has been proposed as an immunologically plausible druggable target that might help prevent ARDS in these patients, although this remains to be further tested (Box 1) [59, 72, 78, 80] .

In summary, T cell dysregulation in COVID19 appears to depend on both a quantitative and qualitative modification that might render T cells overreactive and exhausted: one the one hand, able to fuel inflammation, and on the other hand, under-performing in their antiviral function.

Epidemiological reports describing the mortality pattern of COVID-19 patients clearly indicate that age, male-sex, and the number of pre-existing co-morbidities are key risk factors for a high casefatality rate of SARS-CoV-2 infection [6, 7] . These conditions are characterized by a higher basal pro-inflammatory status coupled with a progressive inability by the immune system to mount proper responses -that might be referred to as "immunosenescence" in aging individuals [81] (Box 2). Accordingly, SARS-CoV-2 has caused more severe interstitial pneumonia in old compared to young macaques, paralleled by more active viral replication (in nasopharyngeal swabs) in the former, demonstrating age-dependent, impaired viral clearance [82] .

An age-dependent reduction in peripheral blood T cell numbers was indeed observed in COVID-19 patients, with the lowest count reported in patients older than 60 years, suggesting that a decline in both CD4 + and CD8 + T cell numbers might be a potential cause for increased susceptibility to SARS-CoV-2 infection in elderly patients [46] . Furthermore, weakened adaptive responses and J o u r n a l P r e -p r o o f elevated systemic inflammation might dramatically compromise antiviral responses and might be key drivers of SARS-CoV-2-induced mortality [83] , although further robust studies are warranted to address these possibilities.

An additional insight regarding sex-dependent differences in terms of immune-related aging comes from chromatin accessibility and RNA-seq analyses showing that older women (> 65 years) have higher genomic activity compared to age-matched older men, as evidenced from transcription factor expression in adaptive immune cells; by contrast, the older men comparatively exhibited a greater age-related CD4 + and CD8 + T cell decline, and higher concentrations of circulating proinflammatory IL-6 and IL-18 cytokines [84] . This sexual-dimorphism in human immune system aging might be key in helping to explain some of the reported sex-specific differences in COVID-19 clinical characteristics, in which relative to females, age and comorbidities are associated with greater susceptibility to disease in male patients, when considering prognosis [85] .

Beyond age and gender, several additional risk factors can contribute to the development of a chronic, low-grade inflammatory status. Among these, obesity and the resulting adipose tissue dysfunction have clearly emerged as a major fuel of both local and systemic inflammatory responses [86, 87] . Indeed, generally, a number of triggers linked to overnutrition, e.g. glucose, cholesterol derivatives, and free fatty acids, can promote the activation of multiple inflammatory pathways, including signaling via IKK complex-NF-kB and JNK-AP1, or inducing reticulum stress by stimulating pattern recognition receptors (PRRs) in both adipocytes and adipose tissueresident immune cells [88] . The local inflammatory response is mirrored in the plasma of obese patients, characterized by high circulating concentrations of multiple pro-inflammatory mediators, such as IL-6, IL-8, MCP-1, TNFα, and hs-CRP [89, 90] ; these conditions can also foster or precipitate premature immunosenescence ex vivo, as evidenced by decreased expression of CD28 in human peripheral CD8 + T cells [91] . Obese subjects are more prone to suffer from selected infectious diseases, such as surgical-site infections, pancreatitis, and skin infections harbor an increased risk of poor prognosis when infected [92] . Although the underlying mechanisms are still a J o u r n a l P r e -p r o o f matter of investigation, a recent meta-analysis suggested that obesity as a comorbidity, might increase the risk for hospitalization, ICU admission, and death among patients with COVID-19 [93] .

Overall, although warranting further and rigorous investigation, these observations suggest that a deeper understanding of immune remodeling during aging in the two sexes and in dysmetabolic conditions might provide crucial information that could influence the development of targeted drugs to limit SARS-CoV-2-induced mortality.

In contrast with infected adults, most children experience a milder COVID-19 clinical course [94, 95] . Pediatric cases are classified as severe and critical (respectively 2.5% and 0.6%), and are significantly less frequent than in adults [96] [97] [98] [99] [100] . Age disparities observed in severe cases might be due to a lower susceptibility of children to infection, a lower propensity to showing clinical symptoms, or both. A mathematical model based on epidemiological data from China, Italy, Japan, Singapore, Canada, and South Korea, estimated that susceptibility to infection in subjects younger than 20 years might be half than that of adults, with clinical symptoms manifesting from 21% of infections in 10-to 19-year-olds, to 69% in individuals aged over 70 years [101] .

Since SARS-CoV-2 has emerged as a novel human virus, individuals remain naïve and should be equally susceptible to being infected, while the immunological milieu that is in contact with the virus presumably significantly differs in children compared with adults. During the immune trajectory from the neonatal age into adulthood, the clonal composition of the expressed T cell receptor (TCR) repertoire changes from a highly diversified set of antigen-specific TCRs, to a less diverse and more oligoclonal collection of TCR molecules, possibly as a result of immune responses to past infections [102] . Moreover, at birth, nearly all T lymphocytes express CD45RA, a typical marker of naïve cells [103] . A study analyzing the immune dynamics of healthy individuals J o u r n a l P r e -p r o o f from 5 to 96 years, showed that peripheral blood naïve CD4 + and CD8 + T cell numbers decrease linearly with age; circulating memory cells outnumber naïve cells around 35 years of age and subjects aged 65 years or older are characterized by an extremely reduced naïve T cell repertoire (Figure 2) [104] . These different cellular frequencies have been associated with lower CD4 + and CD8 + T cell activation and multifunctional populations of healthy pediatric T cells upon in vitro stimulation, as well as less severe toxic shock syndrome-associated morbidity in children compared to adults [105] . Furthermore, early-life naïve CD4 + T cells isolated from healthy fetal tissues (18) (19) (20) (21) (22) gestational weeks) tend to differentiate towards a Foxp3 + CD25 + Treg cell phenotype and persist for an extended period of time (compared to healthy adult naïve CD4 + T cells), shaping a stable antiinflammatory profile [106] .

On the one hand, the accumulation of immunological memory upon entering adult life provides higher protection from infections and indeed, young adults suffer fewer infections than children. On the other hand, immunological memory can also be detrimental for the host. As a remarkable example, it has been hypothesized that many young adults who succumbed to the "1918" H1N1 influenza virus infection, had developed a deadly illness because of a triggered excessive inflammatory cellular response and the recruitment of an overwhelming number of cross-reactive CD8 + T cells, possibly having been infected with another strain of influenza virus in their infancy [107] . From another angle, mice studies have demonstrated that immunological memory is acquired throughout life by infections and/or vaccinations, and by commensalism, including in the skin, respiratory tract, and gut microbiome; subsequently, primed CD8 + cytotoxic T cells may "kick in" in response to unrelated viral infections through cross-reactivity, hence augmenting unspecific inflammation [108] . In addition, while T cell proliferation in vivo is presumed to reflect TCRmediated recognition of specific exogenous antigens, memory CD4 + and CD8 + T cells expressing the memory marker CD44, can also be activated via a bystander effect, a recognized phenomenon that induces their proliferation via cytokines instead of TCR triggering [109, 110] . For instance, bystander T cells are not pathogen-specific, and have been reported to contribute to a protective J o u r n a l P r e -p r o o f immune response via rapid production of IFN-γ during acute hepatitis A viral infections [109] .

However, memory (but not naïve) CD4 + T cells have produced IL-17A in the absence of TCR engagement and increased the expression of pathogenic Th17 signature genes, such as those encoding CCR6 and GMCSF, in a mouse model of multiple sclerosis, strongly suggesting a pathogenic function of bystander-activated T cells in autoimmunity and host tissue injury [110] .

Thus, we hypothesize that this T cell-mediated bystander effect might be significantly more pronounced in adults than in children upon SARS-CoV-2 infection, given the higher proportion of memory -compared with naïve-T cells in the former subjects, potentially contributing to a massive T cell-derived cytokine release in severely ill adult patients (Key Figure, Figure 2) . We also reason that another potential contributing factor to tissue injury and disease severity in COVID-19 patients might be the effects of trained immunity (Box 3) on both local and systemic inflammation [111] . Of note, although warranting further investigation, the Bacillus Calmette-Guerin (BCG) vaccine has been speculated to confer protection from nonrelated pathogenic viruses, including SARS-CoV-2, through trained immunity: upon challenge with pathogen-associated molecular patterns, innate immune cells can display an enhanced response that promotes antiviral host defense [112, 113] .

Thus, in children infected with SARS-CoV-2, boosting innate antimicrobial mechanisms via trained immunity (such as upon BCG vaccination) might be a potentially beneficial mechanism leading to more efficient inhibition of viral replication and subsequent reduced inflammation. Conversely, an initially amplified -but defective-antiviral innate immune response in some adult, or elder individuals might result in high viral replication and activation of an inefficient systemic inflammation [113, 114] , although this hypothesis remains to be tested. Notwithstanding, trained immunity has indeed been implicated in the persistence of non-resolving inflammation in certain immune-mediated pathologies, such as cardiovascular diseases, as evidenced from animal models and ex-vivo experiments [115] . Consistent with this hypothesis, a prominent pro-inflammatory monocyte/macrophage activation profile has been described in patients with severe COVID-19

infection [43, 57, [116] [117] [118] . In conclusion, we speculate that the abnormal and excessive immune J o u r n a l P r e -p r o o f reaction observed in severe cases of SARS-CoV-2 infection might potentially arise from a pathogenic synergy between T cell-related bystander effects and more pronounced trained innate immunity effects in adults compared to children, reflecting dysregulated adaptive and innate immunity, as well as tissue-damaging inflammation (Key figure, Figure 2) . However, this hypothesis remains to be rigorously explored.

Progression of COVID-19 may be represented by three phases: acute viral replication, hyperactive immunity, and then either recovery, or organ dysfunction, and potentially death.

The key is what decides the outcome between appropriate immunity and immunopathology. Here, we have summarized how T cell-mediated immunity, crucial in the successful clearance of SARS-CoV-2, may instead be dramatically impaired in severe cases of COVID-19, with T cells being both "victims" and active participants of the systemic cytokine storm. In particular, we have evoked trained immunity and bystander T cell activation as potentially powerful biases in the excessive innate and adaptive immune responses to SARS-CoV-2 infection, as revealed in adults but not in children. We posit that these putative mechanisms certainly merit future research efforts.

Deeper investigations into innate, humoral, and T cell-mediated immunity (see Outstanding Questions) during the critical first weeks upon SARS-CoV2 infection -when patients either die or recover -should contribute to providing a roadmap to entangle the molecular mechanisms of COVID19 pathogenesis and host response, and better inform future vaccine design and candidate therapeutics. Perforin creates cell membrane pores, allowing intracellular delivery of granzymes; this leads to cleavage and activation of caspases that induce apoptotic death [119] .

CD4 + T helper (Th) cells orchestrate adaptive immunity by producing cytokines and chemokines that enhance cytotoxic CD8 + T cell responses and are indispensably required for B cell-dependent antibody production and plasma cell generation [120, 121] . These cells respond to class II MHCassociated antigen stimulation and differentiate into functionally distinct subpopulations of effector cells, characterized by specific transcription factors, cytokine fingerprints and pathogenic targets [122] . [123] . b) Th2 cells, whose differentiation is driven by Gata3, stimulate phagocyte-independent, eosinophil-mediated immunity, necessary to combat helminthic parasites. They produce IL-4, IL-5 and IL-13, stimulating the production of IgE antibodies, activate eosinophils, and promote the expulsion of parasites from mucosal tissues [123] . 

Immunosenescence has been described as a complex age-dependent remodeling of the immune system, with many alterations affecting T cells and in particular: i) reduction in the CD4 + /CD8 + T cell ratio; ii) impaired development of CD4 + T follicular helper cells and consequently an altered development of plasma cells and memory B cells; iii) shrinkage of the antigen-recognition repertoire of T cell receptor (TCR) diversity; iv) impaired proliferation in response to antigenic stimulation; v) decreased cytotoxic activity of Natural Killer T cells (NKTs); vi) accrual and clonal J o u r n a l P r e -p r o o f expansion of memory and effector T cells; vii) defective immune defense against viruses, characterized by inefficacious cytotoxic CD8 + T cells; viii) increased circulating concentrations of soluble pro-inflammatory cytokines. This age-associated immune decline may result in an inefficient immune response to novel antigens and an inability to develop proper immunity against infections and upon vaccination. However, the immunosenescence-dependent higher inflammatory status/overactive cytokine secretion might predispose old/frail patients to harmful responses against novel antigens coupled with inefficient viral clearance [81, 125, 126] . Recent work utilized a systems immunology approach and confirmed that human aging is characterized by decreased T cell functions, and a parallel increase in cytotoxic and monocyte cell functions [84] .

Trained immunity is a process that leads to enhanced responsiveness of previously activated innate immune cells, mostly myeloid, to subsequent triggers, hence defined as an "innate immune memory" [111] . The molecular mechanisms implicated in this enhanced innate cell responsiveness are believed to pertain to significant modulation of chromatin organization: innate cell stimulation is accompanied by specific changes in DNA methylation status, unfolding of chromatin, and facilitating gene expression [127] . This DNA rearrangement is only partially removed after cessation of the stimulus, allowing a quicker and enhanced expression of proinflammatory factors after secondary challenge with a novel stimulus [127] . In addition to systemic phenomena, the induction of trained immunity may also takes place at the mucosal level, where long-lived alveolar macrophages display the classical trained phenotype (defense-ready epigenetic signature, high metabolic rate, and increased release of chemokines upon re-stimulation) after a respiratory viral infection, ensuring innate memory independently from monocytes and bone marrow progenitors [128] . As in the case of adaptive memory, trained immunity confers broad benefits for host defense [129] . 

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

A Novel Coronavirus from Patients with Pneumonia in China

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

Antibody responses to SARS-CoV-2 in patients with COVID-19

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals

Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without Seroconversion. medRxiv

Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

The Immune Response and Immunopathology of COVID-19

CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan

Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings

Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis

Clinical and immunological features of severe and moderate coronavirus disease 2019

Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia

The laboratory tests and host immunity of COVID-19 patients with different severity of illness

Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan

Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan

Decreased T cell populations contribute to the increased severity of COVID-19

T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis

Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

IL-6 and CD8+ T cell counts combined are an early predictor of inhospital mortality of patients with COVID-19

Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Rhinovirus and coronavirus infection-associated hospitalizations among older adults

An outbreak of coronavirus OC43 respiratory infection in Normandy, France

Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Multiple organ infection and the pathogenesis of SARS

SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion

Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19

Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis

Can we predict the severity of COVID-19 with a routine blood test?

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Clinical and pathological investigation of severe COVID-19 patients

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19

The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes. medRxiv

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Anakinra for severe forms of COVID-19: a cohort study

Adaptive immune cells temper initial innate responses

Not so fast: adaptive suppression of innate immunity

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Immunological and inflammatory profiles in mild and severe cases of COVID-19

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

A Dynamic Immune Response Shapes COVID-19 Progression

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Networking at the level of host immunity: immune cell interactions during persistent viral infections

T-cell exhaustion: characteristics, causes and conversion

T cell exhaustion

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

Restoring function in exhausted CD8 T cells during chronic viral infection

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4<sup>+</sup> T cells. bioRxiv

Regulatory T cells in the control of host-microorganism interactions (*)

CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions

T cell responses to whole SARS coronavirus in humans

Th2 predominance and CD8+ memory T cell depletion in patients with severe acute respiratory syndrome

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Signals of Th2 immune response from COVID-19 patients requiring intensive care

COVID-19: a case for inhibiting IL-17?

Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? Front Immunol 8

Age-related rhesus macaque models of COVID-19

Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia

Sexual-dimorphism in human immune system aging

Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients

Inflammation, metaflammation and immunometabolic disorders

Inflammageing and metaflammation: The yin and yang of type 2 diabetes

An Integrated View of Immunometabolism

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo

Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes

Immunosenescence Induced by Plasma from Individuals with Obesity Caused Cell Signaling Dysfunction and Inflammation

Obesity and the risk and outcome of infection

Obesity in patients with COVID-19: a systematic review and metaanalysis

SARS-CoV-2 Infection in Children

Clinical Analysis of 25 Novel Coronavirus Infections in Children

Epidemiology of COVID-19 Among Children in China

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19)-United States

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Age-dependent effects in the transmission and control of COVID-19 epidemics

The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study

Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment

Differences Between Pediatric and Adult T Cell Responses to

Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans

Host Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza Pandemic

Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses

The activation of bystander CD8+ T cells and their roles in viral infection

Pathogenic function of bystander-activated memory-like CD4(+) T cells in autoimmune encephalomyelitis

Trained Immunity: An Ancient Way of Remembering

Is BCG vaccination affecting the spread and severity of COVID-19? Allergy

BCG-induced trained immunity: can it offer protection against COVID-19?

COVID-19: consider cytokine storm syndromes and immunosuppression

Trained immunity and atherosclerotic cardiovascular disease

Aberrant pathogenic GM-CSF<sup>+</sup> T cells and inflammatory CD14<sup>+</sup>CD16<sup>+</sup> monocytes in severe pulmonary syndrome patients of a new coronavirus

Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients. medRxiv

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

The CD8 T Cell Response to Respiratory Virus Infections

Expanding roles for CD4(+) T cells in immunity to viruses

T-cell-B-cell cooperation

The plasticity of human Treg and Th17 cells and its role in autoimmunity

The functional plasticity of T cell subsets

Development and maintenance of regulatory T cells

2020) T cells, aging and senescence

Cellular Senescence and Inflammaging in Age-Related Diseases

Defining trained immunity and its role in health and disease

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity

Trained immunity confers broad-spectrum protection against bacterial infections

The authors want to truly thank the clinicians, nurses and all healthcare professionals who have worked and are working tirelessly on the frontlines of the COVID-19 pandemic. We also want to